Spitzwieser et al. investigated RASSF1A promoter methylation status in 17 breast cancer samples and their matched normal adjacent tissues using MS-HRMA and found high methylation frequencies in tumors and adjacent tissues, but no correlation between their methylation status [41]. The gene discussed is RASSF1; the disease is breast carcinoma.